Edition:
United Kingdom

IHH Healthcare Bhd (IHHH.KL)

IHHH.KL on Kuala Lumpur Stock Exchange

5.66MYR
13 Sep 2019
Change (% chg)

-- (--)
Prev Close
RM5.66
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,460,669
52-wk High
RM5.95
52-wk Low
RM4.54

Summary

Name Age Since Current Position

Mohammed Azlan bin Hashim

62 2018 Independent Non-Executive Chairman of the Board

See Leng Tan

54 2014 Chief Executive Officer, Managing Director, Non-Independent Executive Director

Soon Teck Low

54 2016 Group Chief Financial Officer

Aziz Baba Abdul

63 2018 President - IMU Health Sdn Bhd, Chief Executive Officer, Vice-Chancellor - IMU Education Sdn Bhd

Boon Kheng Chan

51 2018 Group Head, Strategic Planning & Business Development, (Merger & Acquisition), Chief Executive Officer - South East Asia Operations Division

Tahsin Guney

52 2019 Chief Executive Officer - Acibadem Saglik Yatirimlari Holding A.S

Suet Wun Lim

59 2018 Group Chief Operating Officer

Fay Lin Teo

50 2017 Group Chief Human Resource Officer

Chi-Keon Loh

45 2019 Executive Director

Nili Shayrina Binti Saat

44 2018 Head - Risk Management

lok Sen Huang

63 2013 Group Head - Internal Audit

Ida Suryati Binti Ab Rahim

2019 Joint Secretary

Mehmet Ali Aydinlar

62 2019 Non-Independent Non-Executive Director

Chintamani Aniruddha Bhagat

49 2016 Non-Independent Non-Executive Director

Koji Nagatomi

58 2017 Non-Independent Non-Executive Director

Takeshi Saito

47 2019 Non-Independent Non-Executive Director

Shirish Apte

66 2014 Independent Non-Executive Director

Rossana Annizah binti Ahmad Rashid

53 2012 Non-Executive Independent Director

Jill Watts

60 2018 Non-Executive Independent Director

Penelope Koh

2018 Vice President - Investor Relations

Biographies

Name Description

Mohammed Azlan bin Hashim

Dato' Mohammed Azlan bin Hashim has been re-designated as an Independent Non-Executive Chairman of the Board of the Company. Dato’ Mohammed Azlan bin Hashim was appointed to the Board of IHH Healthcare Berhad (“IHH”) in 2011 as Deputy Chairman and was re-designated from Non-Independent Non-Executive Deputy Chairman to Non-Independent Non-Executive Chairman on 1 January 2018. On 27 November 2018, Dato’ Mohammed Azlan bin Hashim was re-designated from Non-Independent Non-Executive Chairman to Independent Non-Executive Chairman following his cessation as a nominee director of Khazanah Nasional Berhad. Dato’ Azlan previously served as Executive Chairman of the (then) Kuala Lumpur Stock Exchange Group from 1998 to 2004 and in various other senior management roles, including at Bumiputra Merchant Bankers Berhad and Amanah Capital Malaysia Berhad. He holds Bachelor of Economics, Monash University, Fellow Member, Institute of Chartered Accountants, Australia. Member, Malaysian Institute of Accountants. Fellow Member, The Malaysian Institute of Chartered Secretaries and Administrators.

See Leng Tan

Dr. Tan See Leng is Chief Executive Officer, Managing Director, Non-Independent Executive Director of IHH Healthcare Berhad., since January 1, 2014. Dr Tan See Leng was appointed the Managing Director and Chief Executive Officer of IHH Healthcare Berhad (“IHH”) in January 2014 after serving as an Executive Director on the IHH Board for two years. Dr Tan is also the Group CEO and Managing Director of Parkway Pantai Limited, a position he assumed in 2011. He also serves on the Boards of IHH subsidiaries, namely Parkway Pantai Limited, Fortis Healthcare Limited, SRL Limited and Acibadem Saglik Yatirimlari Holding A.S. (“ASYH”) Group and on a Board Committee of ASYH. He also serves on the Advisory Board of Lee Kong Chian School of Business at Singapore Management University and on the Board of Parkway Trust Management Limited (“PTM”), an indirect wholly-owned subsidiary of IHH. PTM manages Parkway Life Real Estate Investment Trust, which is listed on the Singapore Exchange Securities Trading Limited. Prior to this, Dr Tan was the CEO of Parkway Holdings Limited from April 2010, a position he rose to fairly quickly after he joined Parkway in 2004 as Chief Operating Officer of Mount Elizabeth Hospital. As a young entrepreneur, Dr Tan founded a private primary healthcare group at the age of 27 and subsequently developed it into the second largest primary healthcare group in Singapore before successfully selling the company to a leading global health-plan and insurance provider. He holds Bachelor of Medicine and Bachelor of Surgery (MBBS), National University of Singapore, Master of Medicine (Family Medicine), National University of Singapore, Master of Business Administration, University of Chicago Booth School of Business.

Soon Teck Low

Mr. Low Soon Teck is Group Chief Financial Officer at IHH Healthcare Berhad., since January 10, 2016. Mr. Low Soon Teck assumed the position of Group Chief Financial Officer of IHH Healthcare Berhad (“IHH”) on 10 January 2016. He brings with him over 20 years of experience in finance, legal and general management in leadership roles. Prior to joining IHH, Mr Low served with the RCMA Group, a commodities supply chain management company, as its Chief Financial Officer between 2013 and 2015. From 1994 to 2013, he was employed in the Kuok/Kerry Group, holding various senior positions in diverse businesses within the group in Hong Kong and Singapore. His last position in the group was as Chief Financial Officer of the PACC Offshore Services Holdings Group, the offshore marine arm of the Kuok/Kerry Group. Prior to this, Mr Low served as Group Treasurer at Wilmar International Limited, after its merger in 2006 with Kuok Oils and Grains where he had served as Group Financial Controller following his relocation from Hong Kong to Singapore in 2005. He earned Bachelor of Laws (Hons) (2nd Upper), National University of Singapore, Master of Business Administration, University of Chicago, Booth School of Business. Advocate and Solicitor, Supreme Court of Singapore. Member of Law Society of England and Wales

Aziz Baba Abdul

Prof. Abdul Aziz Baba is President - IMU Health Sdn Bhd, Chief Executive Officer, Vice-Chancellor - IMU Education Sdn Bhd of the Company. Professor Abdul Aziz Baba was promoted as the President of IMU Health Sdn Bhd, a wholly-owned subsidiary of IHH Healthcare Berhad (“IHH”), on 1 January 2018. Since 1 January 2016, he is also the Chief Executive Officer and Vice-Chancellor of IMU Education Sdn Bhd, a wholly-owned subsidiary of IHH, responsible for operating the International Medical University (“IMU”). Prior to assuming this role, Prof Aziz served as Vice President of IMU since 1 November 2013, a role he was promoted to since joining IMU in 1 July 2013 as Vice President with responsibility for the Medical and Dental Programme. Before he joined IMU, Prof Aziz held several key academic administrative positions at the School of Medical Sciences (SMS) of Universiti Sains Malaysia (USM). These included the positions of Dean (2005–2012) and Deputy Dean (2003–2005). Preceding this he served as a Professor (2000), Associate Professor (1992) and Lecturer and Clinical Haematologist/ Oncologist at USM’s SMS, following the completion of his postgraduate training in 1986. During his tenure with USM, Prof Aziz was instrumental in establishing the Clinical Haematology and Stem Cell Transplantation service at USM’s teaching hospital, HUSM. He holds Bachelor of Medicine and Bachelor of Surgery (MBBS), University of Melbourne, Australia.

Boon Kheng Chan

Dr. Chan Boon Kheng is Group Head, Strategic Planning & Business Development, (Merger & Acquisition), Chief Executive Officer - South East Asia Operations Division of the Company. Dr. Chan has more than 20 years of healthcare management experience. He had a long association with IHH and its predecessor entity Parkway Healthcare from 2000–2010. Among the various positions held, he was the interim Group Chief Executive Officer of Pantai Holdings Berhad. He returned to IHH in 2018 to lead IHH Strategic Planning and Business Development (M&A) and the CEO for South East Asia Operations. Additionally, he is a Director of Fortis Healthcare Ltd (listed on the India Stock Exchange) and RHT Health Trust Pte. Ltd (listed on the SGX). Prior to joining IHH in 2018, he was a senior advisor to a private equity investment firm. From 2010–2016, he was the Group President of Sasteria Pte Ltd, a privately held healthcare entity, which owns Thomson Medical Group based in Singapore and TMC Life Sciences based in Kuala Lumpur, Malaysia. He concurrently served as the Group CEO of Thomson, as well as the Executive Director of TMC Life Sciences Limited. Dr Chan had also served as an Advisor to a sovereign wealth fund based in Abu Dhabi.

Tahsin Guney

Mr. Tahsin Guney is Chief Executive Officer - Acibadem Saglik Yatirimlari Holding A.S of the Company. Mr Tahsin Güney was appointed as the Chief Executive Officer of Acibadem Saglik Yatirimlari Holding A.S on 1 March 2019. He is a highly experienced healthcare professional with deep knowledge on hospital operations and management. He first joined Acibadem in 2008 as Planning and Business Development Director and has served as Deputy General Manager since 2013. Armed with a Bachelor’s degree in Public Administration and a Master’s degree in Actuarial Science and Statistics, Mr Tahsin Güney started his career in 1990 as an Assistant Inspector at Turkey’s Social Security Agency, where he rose through the ranks to become Acting President and Acting President of the Board in 2008. He holds Bachelor of Public Administration, Middle East Technical University, Ankara, Turkey, Master of Actuarial Science and Statistics, City University, London, UK

Suet Wun Lim

Dr. Suet Wun Lim is Group Chief Operating Officer of the Company. He brings more than 30 years of experience in healthcare management. Dr Lim has served Parkway Pantai since 2011, first as Executive Vice President Singapore and then as the Chief Executive Officer, Parkway Operations Division, before assuming the role of Group COO of Parkway Pantai. Prior to joining Parkway, Dr Lim was the CEO of the National Healthcare Group and Tan Tock Seng Hospital (TTSH). In 2003, Dr Lim led the TTSH team through the SARS crisis, when the hospital was designated the SARS hospital for the whole of Singapore. For his leadership, he was awarded the Public Service Star by the President of Singapore. Dr Lim was also the former chairman of the Board of Joint Commission International (JCI). He earned Bachelor of Medicine and Bachelor of Surgery (MBBS), National University of Singapore, Master of Business Administration, University of California, Los Angeles & Master of Public Health, University of California, Los Angeles.

Fay Lin Teo

Ms. Sharon Teo Fay Lin is Group Chief Human Resource Officer of the Company. Ms Sharon Teo Fay Lin joined IHH Healthcare Bhd (“IHH”) on 10 March 2017. She is a Human Resources practitioner with more than twenty years’ HR experience across a broad spectrum of pharmaceutical, manufacturing and FMCG MNCs and local enterprises. Prior to joining IHH, Ms Teo served with Avery Dennison Singapore Pte Ltd in various positions, beginning as the HR Director for its’ ASEAN business before leading Integration and Transformation at the East Asia and Pacific level. She was subsequently promoted as the HR Director for the Materials Group at the ASEAN level. Preceding this, Ms Teo held senior positions in pharmaceutical and healthcare MNCs, such as Novartis Asia Pacific Pharmaceutical Pte Ltd, where she served as the Human Resources Manager and Regional Human Resources Manager, Asia Pacific before being promoted as the Head of Talent Management, Organization Development and Staffing, Asia Pacific. Prior to that, she served at Bausch & Lomb Sdn Bhd as the Regional Human Resources Administrator, South Asia before rising to the position of Human Resources and Administration Manager, Malaysia and Singapore. Ms Teo began her career at Yeo Hiap Seng (M) Berhad as a Human Resources Executive in 1993. She holds Bachelor of Arts in Psychology, Anthropology and Sociology, National University of Malaysia • Certificate in Personnel Management, Malaysian Institute of Personnel Management

Chi-Keon Loh

Dr. Loh Chi-Keon is appointed as Executive Director of the Company, effective July 1, 2019. He joins IHH Healthcare Berhad ("IHH") from Columbia Asia Group where he was Chief Executive Officer ("CEO"). Dr Kelvin Loh started his career as a practicing physician before serving for 10 years in the public sector in Singapore, in areas such as clinical services development, hospital planning and hospital operations. Dr Kelvin Loh previously joined the IHH Group in 2008, and between 2008 and 2017 held a number of senior management roles, before taking over as CEO for the Singapore Operations Division, covering among other services, the 4 multi-specialty tertiary hospitals Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East. Dr Kelvin Loh moved to Columbia Asia Group as CEO in 2017 where he was responsible for overseeing Columbia Asia Group's 28 hospitals across 4 countries in Asia including Malaysia and India. Dr Kelvin Loh is a senior healthcare executive with strong track record of delivery. He has extensive experience in leading large healthcare businesses, building relationships with stakeholders, managing hospital operations, financial management and developing people. He is also deeply familiar with the healthcare operating context in diverse countries across Asia.

Nili Shayrina Binti Saat

Ms. Nili Shayrina Binti Saat is Head - Risk Management of the Company. Ms Nili Shayrina binti Saat has more than 20 years of experience in Risk Management with broad industry experiences across property development, constructions, media, oil and gas, hotel, education and agriculture with regional exposure in Indonesia, Thailand, Singapore, India and the Middle East. Prior to joining IHH in 2018, she was the Director of Business Process and Risk Management for Eagle Hills Properties in Abu Dhabi and oversaw the risk management and business process improvement functions. Preceding this she was the Innovation Chief of Iskandar Investment, spearheading the Innovation initiatives for the organisation. She holds Bachelor of Arts (Hons) in Accounting and Finance of Lancaster University, UK.

lok Sen Huang

Ms. Audrey Huang Lok Sen is Group Head - Internal Audit at IHH Healthcare Berhad since March 1, 2013. Ms Audrey Huang was appointed the Group Head of Internal Audit of IHH Healthcare Berhad (“IHH”) on 1 March 2013. In this position, she is responsible for managing the internal audit functions of the Group’s overall system of internal controls, risk and governance. Ms Huang brings to the table more than 30 years experience in auditing, including external audit experience with one of the big four accounting firms as well as internal audit experience with various financial institutions. Prior to joining IHH, Ms Huang had served as the Head of Internal Audit of Parkway Pantai Limited following its incorporation on 21 March 2011. Before that, she was Head of Internal Audit of Parkway Holdings Limited from 21 February 2005. In 2013, she obtained the Certification in Risk Management Assurance (“CRMA”) from the Institute of Internal Auditors, Inc USA, thereby strengthening her portfolio of skills.

Ida Suryati Binti Ab Rahim

Ms. Ida Suryati Binti Ab Rahim is Joint Secretary of the Company. 1. December 2017 - June 2019: Chief Counsel, FGV Holdings Berhad ("FGV") occupation during past 5 years2 . January 2017 - December 2017: Vice President, Sustainability & Environment, FGV 3. May 2016 - January 2017: Vice President, Group Governance and Compliance, FGV 4. July 2014 - April 2016: Vice President, International Business, FGV 5. December 2011 - September 2013: Vice President, Group Secretarial / Group Company Secretary of FGV and its Group of Companies and FGV's listed subsidiary, MSM Malaysia Holdings Berhad

Mehmet Ali Aydinlar

Mr. Mehmet Ali Aydinlar was Non-Independent Non-Executive Director of IHH Healthcare Berhad. He was appointed to the Board of IHH Healthcare Berhad (“IHH”) in 2012, Mr Mehmet Ali Aydinlar is also the Chairman of Acibadem Saglik Yatirimlari Holding A.S. ("ASYH"), a 90%-owned subsidiary of IHH. He was re-designated from Executive Director to Non-Executive Director of IHH on 1 March 2019 following his cessation as the Chief Executive Officer (“CEO”) of ASYH. Mr Mehmet Ali Aydinlar, after an illustrious tenure as founding CEO of ASYH, continues to serve as the Chairman of the Board of the Acibadem group of companies, which includes A Plus, Acibadem Project Management, Acibadem Mobile Services and Acibadem Labmed. He is also the Chairman of the Turkish Accredited Hospitals Association and Vice Chairman of Private Hospitals and Healthcare Institutions Association (OHSAD). As of 2015, Mr Aydinlar has been serving on the board of the Foreign Economic Relations Board (DEIK). This institution is responsible for leading foreign economic relations within the Turkish private sector in a myriad of sectors, as well as for increasing the export volume of Turkish businesses and coordinating similar business development activities. A certified public accountant-turned-entrepreneur, Mr Aydinlar has been recognised for his extensive experience in management and involvement in the healthcare sector since 1993. Mr Aydinlar was chosen “Ernst & Young Entrepreneur of the Year, Turkey” for the year 2018 and in 2015, Mr Aydinlar received the “Lifetime Achievement Award” from Bogazici University, one of the most prestigious higher education institutions in Turkey. Prior to this, he was elected “Business Man of the Year” by the same university. He holds Business Administration Degree, Galatasaray Economy and Management College.

Chintamani Aniruddha Bhagat

Mr. Chintamani Aniruddha Bhagat has been Non-Independent Non-Executive Director at IHH Healthcare Berhad since September 23, 2016. He was appointed to the Board of IHH Healthcare Berhad ("IHH") in 2016, Mr Chintamani Bhagat is the Executive Director in charge of Khazanah Nasional Berhad’s holding in IHH and other investments in the healthcare sector, and is concurrently the head of private markets for South Asia. He also serves on the Boards of IHH subsidiaries, namely Fortis Healthcare Limited and Acibadem Saglik Yatirimlari Holding A.S. ("ASYH") Group and Board Committees of ASYH. Prior to joining Khazanah, Mr Bhagat spent 14 years at McKinsey & Company in Singapore, including six years as Managing Partner for the Singapore office. He was a leader in healthcare practice, serving hospital systems across Asia, as well as a leader in Principal Investor practice, serving several sovereign wealth funds, private equity firms and family owned businesses. He also founded and led McKinsey’s corporate governance service line. Preceding his time at McKinsey, Mr Bhagat was the Chief Executive Officer of an engineering and construction firm in India. He holds Master of Business Administration, INSEAD Business School.

Koji Nagatomi

Mr. Koji Nagatomi is Non-Independent Non-Executive Director of the Company. Mr Koji Nagatomi currently serves as the Managing Officer and Chief Operating Officer, Healthcare and Service Business Unit of Mitsui & Co., Ltd (“Mitsui”) at its Tokyo Headquarters. Between 2011 and 2015, he served in the position of General Manager for several of Mitsui’s divisions. These included Mitsui’s Planning and Administrative Division (Machinery and Infrastructure), First Projects Development Division and Corporate Communications Division. In May 2008, he was appointed Deputy General Manager of Toyo Engineering Corporation’s Corporate Planning Unit. Preceding his tenure at Toyo Engineering Corporation, Mr Nagatomi served as the General Manager of the Infrastructure Project Development Division of Mitsui & Co. (Asia Pacific) Pte Ltd in Kuala Lumpur from December 2003. Prior to that, Mr Nagatomi joined the Project Development Division of Mitsui’s Indonesia Project Section which was based out of Tokyo. He spent eight years at Mitsui & Co. (USA), Inc in Houston under the Plant & Energy Project Development Department after beginning his professional career in 1986 in Mitsui’s Chemical Plant Division. he holds Master’s Degree, Chemical Engineering, Graduate School of Engineering Science, Osaka University.

Takeshi Saito

Mr. Takeshi Saito is Non-Independent Non-Executive Director of the Company. Mr Takeshi Saito was an alternate director to Mr Koji Nagatomi, a role he assumed since April 2017. He was also an alternate director to Mr Satoshi Tanaka, a former Director of IHH, from June 2015 to April 2016. He also serves on certain Boards of IHH subsidiaries under Acibadem Saglik Yatirimlari Holding A.S. Group. Mr Saito currently serves as Chief Executive Officer (“CEO”) of MBK Healthcare Management (“MHM”), a wholly-owned subsidiary of Mitsui & Co., Ltd (“Mitsui”) based in Singapore, which manage the healthcare assets within the portfolio of Mitsui. Mr Saito has spent most of his career in the healthcare industry. Preceding his appointment as CEO of MHM, he served as General Manager of Healthcare Business 1st Department in Healthcare Business Division of Mitsui. In 2017, he was an Executive Assistant to a Representative Director and Executive Vice President of Mitsui. Between 2015 and 2016, he was the General Manager of the Provider Network Department, Medical Healthcare Business Division 1, Consumer Service Business Unit of Mitsui and during that time, he also sat on the Board and Executive Committee of Parkway Pantai Limited as an alternate director. In 2011, Mr Saito was seconded to Parkway Group Healthcare as Vice President of Strategic Planning, following his appointment as Director of the Medical Healthcare Business Department at Mitsui, where he led the investment in IHH. He holds Bachelor of Political Science, Keio University, Japan • Master of Business Administration, Kellogg School of Management, Northwestern University.

Shirish Apte

Mr. Shirish Moreshwar Apte is appointed as Independent Non-Executive Director of IHH Healthcare Berhad since September 3, 2014. Mr Shirish Moreshwar Apte is currently also the Independent, Non-Executive, Chairman of Pierfront Mezzanine Fund Pte Ltd. He also serves on the Boards of IHH subsidiaries, namely Fortis Healthcare Limited and Acibadem Saglik Yatirimlari Holding A.S. ("ASYH") and on a Board Committee of ASYH. He concurrently serves on several Boards of Directors, including the Commonwealth Bank of Australia, the Supervisory Board of Bank Handlowy, Poland and Fullerton India Credit Company Limited. He was a Council Member of the Institute of Banking and Finance Singapore until his retirement in May 2018. Prior to his retirement from Citigroup in 2014 as Chairman of Asia Pacific Banking, Mr Apte had built up an impressively extensive 32-year career with Citibank/Citigroup. He held numerous positions with Citibank Citigroup serving in Singapore (2011–2013), Hong Kong (2009–2011), London (2003–2009), Poland (1997–2003) and London (1993–1997). He also supervised operations in the emerging markets covering Central and Eastern Europe, Middle East, Africa (“CEEMEA”) and Asia Pacific. He was appointed head of Citi’s Corporate and Investment bank in India, CEO for Citibank Poland and regional CEO, first for CEEMEA and then Asia Pacific. Mr Apte was also a member of Citigroup’s Executive and Operating Committees from 2008–2012 and the Group’s Business Practices Committee. He began his career in the banking division of Citibank India in 1981. Holds Bachelor of Commerce, Calcutta University, Master of Business Administration — London Business School (Major in Finance), Institute of Chartered Accountants England — Student contract with Touche Ross (now known as Deloitte)

Rossana Annizah binti Ahmad Rashid

Ms. Rossana Annizah binti Ahmad Rashid is Non-Executive Independent Director of IHH Healthcare Berhad since April 17, 2012. Appointed to the Board of IHH Healthcare Berhad (“IHH”) in 2012, Ms Rossana Annizah binti Ahmad Rashid also serves on the Board and Board Committee of Acibadem Saglik Yatirimlari Holding A.S., an indirect subsidiary of IHH. She is also a Non- Executive Director of Parkway Trust Management Limited (“PTM”), an indirect wholly-owned subsidiary of IHH. PTM manages Parkway Life Real Estate Investment Trust which is listed on the Singapore Exchange Securities Trading Limited. Ms Rossana currently serves as the Deputy Chairman on the Board of Cycle & Carriage Bintang Berhad, a member of the Jardine Matheson Group, as Non-Independent Non-Executive Director subsequent to her appointment as Country Chairman of the Jardine Matheson Group of Companies in Malaysia in 2016. Concurrently, she also serves as a member of the Investment Panel and the Investment Panel Risk Committee of Malaysia’s Employees Provident Fund. In May 2017, she was appointed as an Independent Non-Executive Director of Celcom Axiata Berhad. Prior to her current roles, Ms Rossana was a career professional holding leadership positions in the telecommunications and banking sectors. She previously served in various senior management roles with TIME dotCom Berhad, Maxis Berhad and RHB Bank Berhad, after beginning her banking career with Citibank Malaysia. With a combined 30 years of experience, Ms Rossana has broad experience in business strategy, identifying sustainable monetisation models, understanding customers and competition, as well as the need for reviewing monetisation models focusing on both revenue management and cost management. Academic / Professional Qualification(s) • Bachelor of Arts in Banking and Finance, Canberra College of Advanced Education (now known as the University of Canberra), Australia Present Directorship(s) • Cycle & Carriage Bintang Berhad • Celcom Axiata Berhad.

Jill Watts

Ms. Jill Margaret Watts has been Non-Executive Independent Director at the Company since April 4, 2018. Ms Jill Margaret Watts currently serves on the Board of Governors of Sidra Medicine. She was previously a Director of the Australian Chamber of Commerce, United Kingdom, the Royal Australian Flying Doctor Service, United Kingdom, Ramsay Sante in France and the Netcare Group in South Africa. Ms Watts also served on several Industry Boards including NHS Partners Network and the Association of Independent Hospital Operators. Ms Watts was the Group Chief Executive Officer of BMI (GHG) Health Care Group (“BMI Healthcare”) in United Kingdom from 2014 to 2017. She has over 40 years of experience in the healthcare industry and has held a number of senior executive roles in Australia and the United Kingdom. Prior to her appointment at BMI Healthcare, she was the Group Chief Executive Officer of Ramsay Health Care, United Kingdom (“Ramsay UK”) for over six years. She was the Chair of NHS Partners Network between 2009 and 2012, where she was actively engaged in influencing governments on the benefits of having a strong and vibrant private healthcare sector. In 2010, Ms Watts was voted as the most influential leader in United Kingdom private healthcare and in 2013 as one of healthcare’s most inspirational women. Under her leadership, Ramsay UK was voted as the best United Kingdom private hospital provider in 2009 and 2013.

Penelope Koh